{
  "thread": {
    "uuid": "b12b71a96b89e7af0951561ce9badd3dd770c943",
    "url": "https://www.defenseworld.net/2025/12/25/neuraxis-nasdaqnrxs-stock-price-up-9-6-heres-why.html",
    "site_full": "www.defenseworld.net",
    "site": "defenseworld.net",
    "site_section": "https://www.defenseworld.net/feed/atom",
    "site_categories": [
      "media"
    ],
    "section_title": "Defense World",
    "site_title": "Defense World",
    "title": "NeurAxis (NASDAQ:NRXS) Stock Price Up 9.6% - Here's Why - Defense World",
    "title_full": "NeurAxis (NASDAQ:NRXS) Stock Price Up 9.6% - Here's Why - Defense World",
    "published": "2025-12-25T08:43:00.000+02:00",
    "replies_count": 0,
    "participants_count": 1,
    "site_type": "news",
    "country": "US",
    "main_image": "https://www.americanbankingnews.com/wp-content/timthumb/timthumb.php?src=https://www.marketbeat.com/logos/neuraxis-inc-logo-1200x675.png?v=20230911134008&amp;w=240&amp;h=240&amp;zc=2",
    "performance_score": 0,
    "domain_rank": 159846,
    "domain_rank_updated": "2025-12-21T23:00:00.000+02:00",
    "licensing_agency": [],
    "social": {
      "facebook": {
        "likes": 0,
        "comments": 0,
        "shares": 0
      },
      "vk": {
        "shares": 0
      }
    }
  },
  "uuid": "b12b71a96b89e7af0951561ce9badd3dd770c943",
  "url": "https://www.defenseworld.net/2025/12/25/neuraxis-nasdaqnrxs-stock-price-up-9-6-heres-why.html",
  "ord_in_thread": 0,
  "author": "Defense World Staff",
  "published": "2025-12-25T08:43:00.000+02:00",
  "title": "NeurAxis (NASDAQ:NRXS) Stock Price Up 9.6% - Here's Why - Defense World",
  "text": "NeurAxis, Inc. ( NASDAQ:NRXS – Get Free Report ) shares rose 9.6% during mid-day trading on Wednesday . The company traded as high as $3.89 and last traded at $3.8150. Approximately 98,253 shares were traded during trading, a decline of 84% from the average daily volume of 598,177 shares. The stock had previously closed at $3.48. Separately, Craig Hallum upped their price objective on shares of NeurAxis from $7.00 to $8.00 and gave the company a “buy” rating in a report on Monday. One research analyst has rated the stock with a Buy rating, According to data from MarketBeat.com, NeurAxis has an average rating of “Buy” and a consensus target price of $8.00. Get Our Latest Stock Report on NeurAxis The company has a market capitalization of $40.64 million, a PE ratio of -2.07 and a beta of 3.13. The firm has a 50-day moving average of $2.85 and a two-hundred day moving average of $2.69. Several large investors have recently made changes to their positions in NRXS. Wealthcare Advisory Partners LLC acquired a new stake in NeurAxis during the second quarter valued at $37,000. Money Concepts Capital Corp acquired a new position in shares of NeurAxis in the third quarter worth about $103,000. Citadel Advisors LLC boosted its stake in shares of NeurAxis by 39.6% during the 3rd quarter. Citadel Advisors LLC now owns 35,627 shares of the company’s stock worth $110,000 after acquiring an additional 10,103 shares in the last quarter. Manatuck Hill Partners LLC purchased a new stake in shares of NeurAxis during the 2nd quarter worth about $122,000. Finally, AIGH Capital Management LLC grew its position in shares of NeurAxis by 1,913.2% during the 2nd quarter. AIGH Capital Management LLC now owns 400,000 shares of the company’s stock valued at $968,000 after acquiring an additional 380,131 shares during the period. 11.77% of the stock is currently owned by institutional investors and hedge funds. ( Get Free Report )\nNeurAxis (NASDAQ: NRXS) is a clinical-stage biotechnology company focused on the discovery and development of therapeutic candidates for diseases of the central nervous system. The company leverages a proprietary approach to deliver small molecules and biologics across the blood–brain barrier, aiming to address conditions ranging from acute neural injury to chronic neurodegenerative disorders. NeurAxis advances its pipeline through a combination of in-house research, external collaborations with academic medical centers and contract research organizations, and strategic licensing agreements.",
  "highlightText": "",
  "highlightTitle": "",
  "highlightThreadTitle": "",
  "language": "english",
  "sentiment": "positive",
  "categories": [
    "Economy, Business and Finance",
    "Science and Technology"
  ],
  "topics": [
    "Economy, Business and Finance->financial and economic news",
    "Economy, Business and Finance->business and market analysis",
    "Economy, Business and Finance->market and exchange",
    "Science and Technology->biotechnology"
  ],
  "ai_allow": true,
  "has_canonical": false,
  "breaking": false,
  "webz_reporter": false,
  "external_links": [
    "https://marketbeat.com/scripts/336x280AdNewsSites.ashx",
    "https://www.marketbeat.com/stocks/NASDAQ/NRXS/",
    "https://www.marketbeat.com/arnreports/ReportTickerOptin.aspx?RegistrationCode=TickerHyperlink&Prefix=NASDAQ&Symbol=NRXS",
    "https://marketbeat.com/stocks/NASDAQ/NRXS/",
    "https://www.marketbeat.com/scripts/336x280AdNewsSites.ashx",
    "https://marketbeat.com/arnreports/ReportTickerOptin.aspx?RegistrationCode=TickerHyperlink&Prefix=NASDAQ&Symbol=NRXS",
    "https://www.marketbeat.com/arnreports/ReportTickerOptin.aspx",
    "https://www.marketbeat.com/stocks/NASDAQ/NRXS"
  ],
  "external_images": [],
  "internal_images": [],
  "entities": {
    "persons": [
      {
        "name": "Craig Hallum",
        "sentiment": "none"
      }
    ],
    "locations": [],
    "organizations": [
      {
        "name": "Wealthcare Advisory Partners LLC",
        "sentiment": "none",
        "tickers": [
          {
            "ticker": null,
            "exchange": null
          }
        ]
      }
    ]
  },
  "syndication": {
    "syndicated": false,
    "syndicate_id": null,
    "first_syndicated": false
  },
  "trust": {
    "categories": [],
    "top_news": [],
    "bias": null,
    "source": {
      "type": null,
      "city": null,
      "state": null,
      "country": null,
      "domain_type": null,
      "agency": null,
      "organization_name": null
    }
  },
  "rating": null,
  "crawled": "2025-12-25T08:49:13.331+02:00",
  "updated": "2025-12-25T08:54:06.000+02:00"
}